Ma Zhongcai, Jhun BongSook, Oh Chad K
University of California, Los Angeles, UCLA School of Medicine, Division of Allergy and Immunology, Department of Pediatrics, Harbor-UCLA Medical Center, Torrance, CA 90502, United States.
FEBS Lett. 2007 Sep 18;581(23):4485-90. doi: 10.1016/j.febslet.2007.08.034. Epub 2007 Aug 27.
Plasminogen activator inhibitor (PAI)-1 promotes development of asthma. PAI-1 mRNA and protein are markedly induced in activated mast cells (MCs), a major effector cell type in asthma. However, regulatory mechanisms of PAI-1 transcription in MCs are unknown. We present first evidence that PAI-1 is transcriptionally regulated in human MCs (hMCs). In addition to three enhancer regions, we demonstrated that the E-box at -566 bp to -561 bp is the negative regulatory element, and the specific and constitutive binding of the upstream stimulating factor-1 to this E-box is the key mechanism of the negative regulation of PAI-1 expression in hMCs.
纤溶酶原激活物抑制剂(PAI)-1促进哮喘的发展。PAI-1信使核糖核酸和蛋白质在活化的肥大细胞(MCs)中显著诱导产生,而肥大细胞是哮喘中的一种主要效应细胞类型。然而,MCs中PAI-1转录的调控机制尚不清楚。我们首次提供证据表明,PAI-1在人肥大细胞(hMCs)中受到转录调控。除了三个增强子区域外,我们还证明位于-566碱基对至-561碱基对处的E盒是负调控元件,上游刺激因子-1与该E盒的特异性和组成性结合是hMCs中PAI-1表达负调控的关键机制。